CD44 and glioblastoma: Therefore, we evaluated the effect of the TMZ alone or combined with COX-2 inhibitor on the CD44 expression in GBM spheres derived from cells previously treated with CXB, TMZ, or their combination for 72h, and then cultured with macrophages.